Structural model of porcine factor VIII and factor VIIIa molecules based on scanning transmission electron microscope (STEM) images and STEM mass analysis.

Porcine plasma factor VIII (fVIII) molecules are heterodimers composed of a 76,000-mol wt light chain (-A3-C1-C2) and a heavy chain ranging in molecular weight from 82,000 (A1-A2) to 166,000 (A1-A2-B). Proteolytic activation of fVIII by thrombin results in fVIIIa heterotrimers lacking B domains (A1, A2, A3-C1-C2). In this study, immunoaffinity purified fVIII was further fractionated by mono S or mono Q chromatography to prepare heterodimers containing a light chain and an A1-A2-B heavy chain (fVIII 166/76) or an A1-A2 heavy chain (fVIII 82/76). Mass analysis of scanning transmission electron microscopic (STEM) images of fVIII 166/76 indicated that heterodimers (mass 237 +/- 20 kD) had irregularly globular core structures 10-12 nm across, and frequently displayed a diffuse, occasionally globular to ovoid satellite structure extending 5-14 nm from the core, and attached to it by a thin stalk. Factor VIII 82/76 molecules (mass 176 +/- 20 kD) had the same core structures as fVIII 166/76 molecules, but lacked the satellite structure. These findings indicate that A1-A2 domains of heavy chains and the light chains of the fVIII procofactor molecule are closely associated and constitute the globular core structure, whereas the B domainal portion of heavy chains comprises the peripheral satellite appendage. Factor VIII core structures commonly displayed a finger-like projection near the origin of the B domainal stalk that was also a consistent feature of the free heavy chains (mass 128-162 kD) found in fVIII 166/76 preparations. Factor VIII light chain monomers (mass, 76 +/- 16 kD) were globular to c-shaped particles 6-8 nm across. These chains commonly possessed a v-shaped projection originating from its middle region, that could also be observed at the periphery of fVIII core molecules. Factor VIIIa preparations contained heterotrimers (mass 162 +/- 13 kD) that had the same dimensions as fVIII core structures, lacked the B domainal appendage, and sometimes possessed the same core features as fVIII molecules. Molecular species corresponding to heterodimers (mass, 128 +/- 13 kD) and unassociated subunit chains (40-100 kD) were also observed in fVIIIa preparations, suggesting that heterotrimers have an appreciable tendency to dissociate, a phenomenon that could explain the decay of fVIIIa activity after thrombin activation of fVIII.

[1]  R. Kaufman,et al.  Structure-Function Relationships of Factor VIII Elucidated through Recombinant DNA Technology , 1989, Thrombosis and Haemostasis.

[2]  P. Lollar,et al.  Subunit structure of thrombin-activated porcine factor VIII. , 1989, Biochemistry.

[3]  P. Lollar,et al.  Stoichiometry of the porcine factor VIII-von Willebrand factor association. , 1987, The Journal of biological chemistry.

[4]  R. Kaufman,et al.  A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Goodall,et al.  Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies. , 1985, Biochemistry.

[6]  K. Mann,et al.  Studies on the structure of bovine factor V by scanning transmission electron microscopy. , 1985, Blood.

[7]  G. Knutson,et al.  Molecular cloning of a cDNA encoding human antihaemophilic factor , 1984, Nature.

[8]  P. Lollar,et al.  Stabilization of thrombin-activated porcine factor VIII:C by factor IXa phospholipid. , 1984, Blood.

[9]  M. Weinstein,et al.  Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor. , 1984, The Journal of clinical investigation.

[10]  G. Jamieson,et al.  The functional molecular weights of factor VIII activities in whole plasma as determined by electron irradiation. , 1982, The Journal of biological chemistry.

[11]  C. Fulcher,et al.  Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[12]  J. Hainfeld,et al.  Identification and mass analysis of human fibrinogen molecules and their domains by scanning transmission electron microscopy. , 1981, Journal of molecular biology.

[13]  J. Jesty,et al.  The activation and inactivation of human factor VIII by thrombin: effect of inhibitors of thrombin. , 1981, Blood.

[14]  E. Davie,et al.  Formation of a serine enzyme in the presence of bovine factor VIII (antihemophilic factor) and thrombin. , 1977, Science.

[15]  R. Wagner,et al.  Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment. , 1975, The Journal of clinical investigation.

[16]  M. Mosesson,et al.  Molecular Weights of Factor VIII (AHF) and Factor IX (PTC) by Electron Irradiation , 1962, Thrombosis and Haemostasis.

[17]  P. Fay.  Subunit structure of thrombin-activated human factor VIIIa. , 1988, Biochimica et biophysica acta.

[18]  R. Tracy,et al.  Molecular characterization of commercial porcine factor VIII concentrate. , 1988, Blood.

[19]  J F Hainfeld,et al.  Mass mapping with the scanning transmission electron microscope. , 1986, Annual review of biophysics and biophysical chemistry.

[20]  J F Hainfeld,et al.  A small computer system for micrograph analysis. , 1982, Ultramicroscopy.

[21]  L. Hoyer,et al.  The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation. , 1981, The Journal of laboratory and clinical medicine.

[22]  J. Wall.  Limits on visibility of single heavy atoms in the scanning transmission electron microscope: an experimental study , 1979 .